Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In  connection  with the Quarterly  Report of In Vivo Medical  Diagnostics,
Inc.  (the  "Company")  on Form 10-QSB for the quarter ended October 31, 2004 as
filed with the  Securities  and  Exchange  Commission  on the date  hereof  (the
"Report"),  I, In Vivo  Medical  Diagnostics,  Chief  Financial  Officer  of the
Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of
2002, that:

          (1) The Report fully complies with the  requirements  of section 13(a)
     or 15(d) of the Securities and Exchange Act of 1934; and

          (2) The information  contained in the Report fairly  presents,  in all
     material respects,  the financial condition and result of operations of the
     Company.

     A signed  original of this  written  statement  required by Section 906 has
been provided to In Vivo Medical Diagnostics, Inc. and will be retained by Lapis
Technologies,  Inc. and furnished to the Securities  and Exchange  Commission or
its staff upon request.

February 3, 2005                                     /s/ Bernard Turner
                                                     ---------------------------
                                                     Bernard Turner
                                                     Chief Financial Officer